Literature DB >> 15249383

Fundus autofluorescence and vitelliform macular dystrophy.

Juliet E Chung1, Richard F Spaide.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15249383     DOI： 10.1001/archopht.122.7.1078

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  7 in total

Review 1.  The retinal pigment epithelium in health and disease.

Authors:  J R Sparrow; D Hicks; C P Hamel
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

2.  Fundus autofluorescence and the bisretinoids of retina.

Authors:  Janet R Sparrow; Yalin Wu; Takayuki Nagasaki; Kee Dong Yoon; Kazunori Yamamoto; Jilin Zhou
Journal:  Photochem Photobiol Sci       Date:  2010-09-23       Impact factor: 3.982

3.  [Fundus autofluorescence in patients with inherited retinal diseases : patterns of fluorescence at two different wavelengths].

Authors:  T Theelen; C J F Boon; B J Klevering; C B Hoyng
Journal:  Ophthalmologe       Date:  2008-11       Impact factor: 1.059

4.  Genotype-phenotype correlation and longitudinal course in ten families with Best vitelliform macular dystrophy.

Authors:  B Wabbels; M N Preising; U Kretschmann; A Demmler; B Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-04-13       Impact factor: 3.117

5.  Fundus autofluorescence in children and teenagers with hereditary retinal diseases.

Authors:  Bettina Wabbels; Anke Demmler; Karina Paunescu; Erika Wegscheider; Markus N Preising; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-21       Impact factor: 3.117

Review 6.  Functional roles of bestrophins in ocular epithelia.

Authors:  Alan D Marmorstein; Harold E Cross; Neal S Peachey
Journal:  Prog Retin Eye Res       Date:  2009-05-04       Impact factor: 21.198

7.  Atypical vitelliform macular dystrophy misdiagnosed as chronic central serous chorioretinopathy: case reports.

Authors:  Young Seob Lee; Eung-Suk Kim; Moosang Kim; Young-Gyun Kim; Hyung-Woo Kwak; Seung-Young Yu
Journal:  BMC Ophthalmol       Date:  2012-07-20       Impact factor: 2.209
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.